Key result
Pronethalol alters myocardial circulation and catecholamine responses in preclinical models.
Why the study?
Considerable confusion exists regarding the direct effects of cardiac sympathetic nerve stimulation and catecholamines on myocardial vascular tone and the role of sympathetic β-receptors in this process.
This historical preclinical study investigated the effects of beta-receptor blockade with pronethalol on myocardial circulation and catecholamine responses.
Answers are grounded in this paper and cite their sources.
Leaves open mechanism of sympathetic coronary vasodilation; hypothesis-generating, needs prospective validation before clinical inference.
Considerable confusion still exists concerning the action of cardiac sympathetic nerve stimulation and of its supposed mediators, adrenaline and noradrenaline, on the vasculature of the myocardium.The general consensus of opinion is that they produce coronary vaso- dilatation.The disagreement is over the mechanism by which this vasodilatation is produced since not only do cardiac sympathetic nerve stimulation and injections of adrenaline and noradrenaline directly affect vascular tone, but they also modify other factors which influence the state of the myocardial vascular bed (aortic perfusion pressure, heart rate, cardiac metabolism and extravascular support).The problem is whether the direct effect of adrenaline and noradrenaline on the myocardial vessels is vasodilator or vasoconstrictor, the latter effect being masked in the intact animal by mechanical and metabolic factors which lead to vasodilatation.Associated with this problem is the question of whether the sympathetic nerves to the vessels are vasoconstrictor or vasodilator and of whether sympathetic tone exists in this vascular bed.Very little seems to have been done to investigate these problems using substances which block receptor sites.Hashimoto, Shigei, Imai, Saito, Yago, Uei & Clark (1960) found that coronary flow in isolated hearts taken from dogs treated with phenoxybenzamine was greater than in hearts taken from untreated dogs, a finding which can be interpreted as indicating a degree of vasoconstrictor tone for the coronary vessels.It is known, however, that phenoxybenzamine causes the liberation of catechol amines from the adrenal medulla (Millar, Keener & Benfey, 1959) and the high plasma levels of these substances present when the animals were killed would provide an alternative explanation for the increased values for coronary flow obtained.In intact animals, Grayson & Mendel (1961) found that phentolamine, which blocks sympathetic a-receptors, increased myocardial blood flow and decreased myocardial vascular resistance.These effects could similarly be explained by a reduction of sympathetic vasoconstrictor tone although they could also result from the direct vasodilator action which this compound is known to possess.More recently, compounds which block fl-receptors have been produced and one of them, pronethalol (Black & Stephenson, 1962), has been given a trial in the treatment of angina pectoris (Alleyne, Dickinson, Dornhorst, Fulton, Green, Hill, Hurst, Laurence, Pilkington, Prichard, Robinson & Rosenheim, 1963).The present experiments examined the effect of pronethalol on the myocardial circulation and investigated the actions of catechol amines which affect a-and/or ,-receptors (noradrenaline, adrenaline, and isoprenaline) before and after blocking the P-receptors.J. R. PARRATT w 4-Cu.
No takes yet. Share an insight, caveat, or question.
J. R. Parratt (1965) studied Myocardial circulation. Pronethalol was evaluated on Myocardial circulation and actions of catecholamines. An experimental study was conducted to examine the effect of pronethalol on myocardial circulation and catecholamine responses, though no specific results are reported in the abstract.
Synapse has enriched 10 related papers. Consider them for comparative context: